Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000897101-12-000206
Filing Date
2012-02-14
Accepted
2012-02-14 15:45:45
Documents
9
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE QUARTER ENDED DECEMBER 31, 2011 urologix120562_10q.htm 10-Q 248685
2 CERTIFICATION OF CEO PURSUANT TO SECTION 302 urologix120562_ex31-1.htm EX-31.1 12435
3 CERTIFICATION OF CFO PURSUANT TO SECTION 302 urologix120562_ex31-2.htm EX-31.2 11721
4 CERTIFICATION OF CEO/CFO PURSUANT TO SECTION 906 urologix120562_ex32.htm EX-32 4760
  Complete submission text file 0000897101-12-000206.txt   1533798

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ulgx-20111231.xml EX-101.INS 169238
6 XBRL SCHEMA FILE ulgx-20111231.xsd EX-101.SCH 13343
7 XBRL CALCULATION FILE ulgx-20111231_cal.xml EX-101.CAL 30979
8 XBRL LABEL FILE ulgx-20111231_lab.xml EX-101.LAB 119382
9 XBRL PRESENTATION FILE ulgx-20111231_pre.xml EX-101.PRE 73251
Mailing Address 14405 21ST AVENUE NORTH MINNEAPOLIS MN 55447
Business Address 14405 21ST AVE N MINNEAPOLIS MN 55447 6124751400
UROLOGIX INC (Filer) CIK: 0000882873 (see all company filings)

EIN.: 411697237 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-28414 | Film No.: 12609103
SIC: 3845 Electromedical & Electrotherapeutic Apparatus